Cargando…
P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430295/ http://dx.doi.org/10.1097/01.HS9.0000973260.33694.1d |
_version_ | 1785090928774479872 |
---|---|
author | Zhou, Hu Hou, Ming Shi, Yan Jin, Jie |
author_facet | Zhou, Hu Hou, Ming Shi, Yan Jin, Jie |
author_sort | Zhou, Hu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104302952023-08-17 P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL Zhou, Hu Hou, Ming Shi, Yan Jin, Jie Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430295/ http://dx.doi.org/10.1097/01.HS9.0000973260.33694.1d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Zhou, Hu Hou, Ming Shi, Yan Jin, Jie P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL |
title | P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL |
title_full | P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL |
title_fullStr | P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL |
title_full_unstemmed | P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL |
title_short | P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL |
title_sort | p1596: efficacy and safety of ql0911 in adult patients with chronic primary immune thrombocytopenia: a multicenter, randomized, double-blind, placebo-controlled, phase iii trial |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430295/ http://dx.doi.org/10.1097/01.HS9.0000973260.33694.1d |
work_keys_str_mv | AT zhouhu p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial AT houming p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial AT shiyan p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial AT jinjie p1596efficacyandsafetyofql0911inadultpatientswithchronicprimaryimmunethrombocytopeniaamulticenterrandomizeddoubleblindplacebocontrolledphaseiiitrial |